We are live on
!
Find out more
KCM
KRS Capital Management Portfolio holdings
AUM
$215M
1-Year Est. Return
69.3%
This Fund
S&P 500
This Quarter
Est. Return
-3.53%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.8M
AUM Growth
-$6.23M
(-6.2%)
Cap. Flow
-$257K
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
43.99%
Holding
117
New
5
Increased
47
Reduced
35
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$1.45M |
| 2 |
Cadence Design Systems
CDNS
|
+$366K |
| 3 |
Oracle
ORCL
|
+$347K |
| 4 |
Carrier Global
CARR
|
+$290K |
| 5 |
Parker-Hannifin
PH
|
+$246K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$2.85M |
| 2 |
Walt Disney
DIS
|
+$242K |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$228K |
| 4 |
PayPal
PYPL
|
+$227K |
| 5 |
Dollar General
DG
|
+$217K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 51.13% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 7.64% |
| 4 | Financials | 7.3% |
| 5 | Industrials | 5.63% |
Similar funds
VFG
IAM
VEA
RC
NCM
TSS
CMBA
SSA
KRS Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, KRS Capital Management held 117 positions worth $93.8M, down 6.2% from $100M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
KRS Capital Management's Q3 2023 filing shows 5 new, 47 increased, 35 reduced and 6 closed positions. Its largest new stake was Cadence Design Systems: 1,562 shares worth $366K. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.85M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- KRS Capital Management's largest Q3 2023 buy was Cadence Design Systems: 1,562 shares worth $366K.
- KRS Capital Management added most to Bank of America in Q3 2023, an estimated $1.45M increase.
- KRS Capital Management's biggest Q3 2023 reduction was Walt Disney, cutting an estimated $242K.
- KRS Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.85M.
- KRS Capital Management's ten largest holdings make up 44% of its $93.8M portfolio in Q3 2023.
- KRS Capital Management opened 5 new positions and closed 6 in Q3 2023.
- KRS Capital Management's portfolio value fell 6.2% quarter-over-quarter to $93.8M.
Based on KRS Capital Management's 13F filing for Q3 2023, filed 19 Oct 2023.